Organising the right technology team is a pre-requisite for the deployment of success. However, ensuring that you…
Biocon: A Credibly Capable Organization
On July 15, 2016, Biocon Ltd. announced the launch of a high quality, yet affordable biosimilar version of Sanofi’s blockbuster Lantus drug for patients of diabetes in Japan. Lantus, or Insulin Glargine, is a biologic. In contrast to conventional drugs that are synthesized from chemicals, a biologic is manufactured in a living system such as a microorganism or plant or animal cells. Most biologics are large, complex molecules and are produced using recombinant DNA technology. Biologics are one of the most significant developments of modern science as they potentially offer the most effective means to treat a variety of medical conditions that presently have no other treatments available……….
Read More
The 25 Best Companies to Work for in Asia
Advanced tools and methodologies have become absolutely essential to achieve the necessary productivity, quality, cost…
With the depleting levels of fossil fuels and increasing levels of pollution, the requirement of…
The sea is vast and wild, but if we can tame some of its uncertainties,…
Artificial Intelligence (AI) has become a dominant enterprise technology as businesses strive to stay ahead…
The boom in the usage of smartphones and data intensive devices has amicably boosted up…
In banking and payment industry, the real challenge is to provide payment based innovative solutions…
CXO Standpoint
We used to say that the storytelling business is all about the people. Talents from…
Digital marketing revolutions are real and are creating disruptions for marketing operations. Marketers are now…
Quality/Quantity
Nowadays! Everyone wants to succeed in their businesses, want to deliver their best quality products,…
Tech-Facts
Every organization has its unique requirements, for developing a good accessible technology plan. As experts…
Workodynamics
Here are four words we don’t hear very often: “I love my job.” An extensive…